Macular Degeneration

Macular Degeneration Symptoms

Macular Degeneration Treatment

Macular Degeneration Treatment

Macular Degeneration Treatment

Ranibizumab (Lucentis) Pegaptanib (Macugen)

Antibody fragment that binds to VEGF-A isoforms Oligonucleotide that binds to VEGF-165

Loading phase of one injection per month for 3 consecutive months, followed by a maintenance phase

Intravitreal injection into the affected eye administered once every 6 weeks (9 injections per year)

Cost per injection = £761.20

2-year cost up to £18,300 assuming 12 injections in the first year and another 12 in the second year

Cost per injection = £514.00

2-year cost up to £9,300 assuming 9 injections in the first year and another 9 in the second year

TA 155

Ranibizumab and pegaptanib for the treatment of age-related macular degeneration  Full url- http://publications.nice.org.uk/ranibizumab-and-pegaptanib-for-the-treatment-of-age-related-macular-degeneration-ta155